Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
US11345691B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 2020 |
| Grant date | May 31, 2022 |
| Priority date | — |
| Expiry date | Jun 25, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to prodrug compounds and their use in the treatment of Cystic Fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.